Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs
- PMID: 25344812
- PMCID: PMC4232468
- DOI: 10.1038/nchembio.1661
Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs
Erratum in
-
Corrigendum: Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs.Nat Chem Biol. 2015 Mar;11(3):235. doi: 10.1038/nchembio0315-235d. Nat Chem Biol. 2015. PMID: 25689338 No abstract available.
-
Erratum: Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs.Nat Chem Biol. 2015 Sep;11(9):741. doi: 10.1038/nchembio0915-741c. Nat Chem Biol. 2015. PMID: 26284675 No abstract available.
Abstract
Agonists of mouse STING (TMEM173) shrink and even cure solid tumors by activating innate immunity; human STING (hSTING) agonists are needed to test this therapeutic hypothesis in humans. The endogenous STING agonist is 2'3'-cGAMP, a second messenger that signals the presence of cytosolic double-stranded DNA. We report activity-guided partial purification and identification of ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP1) to be the dominant 2'3'-cGAMP hydrolyzing activity in cultured cells. The hydrolysis activity of ENPP1 was confirmed using recombinant protein and was depleted in tissue extracts and plasma from Enpp1(-/-) mice. We synthesized a hydrolysis-resistant bisphosphothioate analog of 2'3'-cGAMP (2'3'-cG(s)A(s)MP) that has similar affinity for hSTING in vitro and is ten times more potent at inducing IFN-β secretion from human THP1 monocytes. Studies in mouse Enpp1(-/-) lung fibroblasts indicate that resistance to hydrolysis contributes substantially to its higher potency. 2'3'-cG(s)A(s)MP is therefore improved over natural 2'3'-cGAMP as a model agonist and has potential as a vaccine adjuvant and cancer therapeutic.
Figures





Similar articles
-
Identification of the extracellular membrane protein ENPP3 as a major cGAMP hydrolase and innate immune checkpoint.Cell Rep. 2024 May 28;43(5):114209. doi: 10.1016/j.celrep.2024.114209. Epub 2024 May 14. Cell Rep. 2024. PMID: 38749434
-
Structural insights into cGAMP degradation by Ecto-nucleotide pyrophosphatase phosphodiesterase 1.Nat Commun. 2018 Oct 24;9(1):4424. doi: 10.1038/s41467-018-06922-7. Nat Commun. 2018. PMID: 30356045 Free PMC article.
-
Tumor Exosomal ENPP1 Hydrolyzes cGAMP to Inhibit cGAS-STING Signaling.Adv Sci (Weinh). 2024 May;11(20):e2308131. doi: 10.1002/advs.202308131. Epub 2024 Mar 18. Adv Sci (Weinh). 2024. PMID: 38498770 Free PMC article.
-
ENPP1, an Old Enzyme with New Functions, and Small Molecule Inhibitors-A STING in the Tale of ENPP1.Molecules. 2019 Nov 19;24(22):4192. doi: 10.3390/molecules24224192. Molecules. 2019. PMID: 31752288 Free PMC article. Review.
-
Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 inhibitors: Research progress and prospects.Eur J Med Chem. 2024 Mar 5;267:116211. doi: 10.1016/j.ejmech.2024.116211. Epub 2024 Feb 10. Eur J Med Chem. 2024. PMID: 38359537 Review.
Cited by
-
The cGAS-STING pathway as a therapeutic target in inflammatory diseases.Nat Rev Immunol. 2021 Sep;21(9):548-569. doi: 10.1038/s41577-021-00524-z. Epub 2021 Apr 8. Nat Rev Immunol. 2021. PMID: 33833439 Free PMC article. Review.
-
Cytosolic DNA sensing by cGAS: regulation, function, and human diseases.Signal Transduct Target Ther. 2021 Apr 30;6(1):170. doi: 10.1038/s41392-021-00554-y. Signal Transduct Target Ther. 2021. PMID: 33927185 Free PMC article. Review.
-
Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy.J Clin Med. 2020 Oct 16;9(10):3323. doi: 10.3390/jcm9103323. J Clin Med. 2020. PMID: 33081170 Free PMC article. Review.
-
USP15 promotes cGAS activation through deubiquitylation and liquid condensation.Nucleic Acids Res. 2022 Oct 28;50(19):11093-11108. doi: 10.1093/nar/gkac823. Nucleic Acids Res. 2022. PMID: 36243958 Free PMC article.
-
The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo.Elife. 2015 Apr 21;4:e06670. doi: 10.7554/eLife.06670. Elife. 2015. PMID: 25898005 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous